Dysfunction in GHRH-R signaling is associated with abnormal growth, making GHRH-R an attractive therapeutic target against dwarfism (e.g., isolated GH deficiency, IGHD), gigantism, lipodystrophy and certain cancers. This evidence concerns the gene GHRHR and cancer.